News
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
5d
TipRanks on MSNGSK’s Promising Study on Belimumab for Systemic Sclerosis Lung DiseaseGlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...
Inhalational exposures to smoking, asbestos, dust, metals, and organics significantly increase the odds of developing interstitial lung disease.
The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.
The FDA on Friday granted accelerated approval to zongertinib (Hernexeos) for non-squamous non-small cell lung cancer (NSCLC) ...
Using triple therapy with belimumab for initial lupus nephritis treatment was associated with early renal response in a study of real-world patients.
Their findings, demonstrated across cell cultures, preclinical models, and samples of human lung tissue, show that blocking Epac1 can slow the progression of the disease.
A more aggressive form of black lung disease is showing up among young miners.
Individuals with vs. without interstitial lung disease faced an elevated risk for lung cancer and histological subtypes of lung cancer in adjusted and sibling-controlled analyses, according to results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results